Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel farnesoid X receptor agonists described by Enanta Pharmaceuticals

April 25, 2018

FDA grants RMAT designation to ABO-102 for MPS IIIA

April 25, 2018

Shire willing to recommend Takeda's revised proposal to shareholders

April 25, 2018

Researchers present novel IDO-1 inhibitor for cancer

April 25, 2018

FDA approves Jynarque to slow kidney function decline in adults with ADPKD

April 25, 2018

Takeda set to begin voluntary and conditional public takeover bid for TiGenix

April 25, 2018

Curadev Pharma targets ACSS2 for antitumor agents

April 25, 2018

Boehringer Ingelheim and Topas Therapeutics enter research agreement

April 25, 2018

First patient enrolled in phase III trial of topical ocular reproxalap

April 25, 2018

Results on sodium oxybate presented in pediatric patients with narcolepsy type 1

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...